ACADIA Pharmaceuticals Inc. (ACAD) Earnings
NASDAQ·Healthcare·Biotechnology
$21.15
-1.12%
Mkt Cap $3.66B
EPS — Estimate vs Actual
Mkt Cap
$3.66B
P/E
9.61
Fwd P/E
55.27
P/S
3.34
Rev TTM
—
EPS TTM
$2.20
NASDAQ·Healthcare·Biotechnology
$21.15
-1.12%
Mkt Cap $3.66B
Mkt Cap
$3.66B
P/E
9.61
Fwd P/E
55.27
P/S
3.34
Rev TTM
—
EPS TTM
$2.20